IBEC Seminar: Cristina Canal
Cold atmospheric plasma: a novel potential therapy for cancer treatment
Cold atmospheric plasma: a novel potential therapy for cancer treatment
Cold atmospheric plasma: a novel potential therapy for cancer treatment
Cold atmospheric plasma: a novel potential therapy for cancer treatment
The project, which is the brainchild of IBEC group leader Pere Roca-Cusachs and proposes the targeting of tumor mechanics to develop new drugs for oncology, specifically with pancreatic cancer in mind, was pitched by IBEC Technology Transfer manager Diana Gonzalez at the meeting on Friday.
Diana, involved in the project from its onset, was one of twelve finalists chosen to present in six-minute pitches to a panel of judges. The project was shortlisted because of its solid focus on an unmet medical, market or patient need, and because it proposed using innovative technology to create a product or service.
The gathering, promoted by the “la Caixa” Banking Foundation – which currently holds the vice-presidency of the BIST Board of Trustees – kicked off with a keynote speech by US scientist Barry C. Barish, winner of the 2017 Nobel Prize in Physics, entitled ‘Gravitational Waves: From Einstein to a New Science’.
At ‘IDEACIÓ: Connecting CataloniaBio & HealthTech and Advanced Materials’ held at the headquarters of INNOVAMED in Barberà del Vallès on Friday, Javier presented the new and potential advanced materials being used in 3D bioprinting in the area of regenerative medicine.
Application Deadline: 20/07/2018
Ref: MC-LA
The Nanoscopy for Nanomedicine group at the Institute for Bioengineering of Catalonia (IBEC) is looking for an Early Stage Researcher (PhD student) to develop his PhD thesis project on the super-resolution imaging of bio-orthogonal catalytic nanoparticles. The contract will be within the framework of the THERACAT Marie Skłodowska-Curie European Training Network (H2020-MSCA-ITN-2017, Project 765497), whose objective is to train a new generation of early-stage researchers on new catalysis-based cancer therapies.
Regulation of cell division and cell cycle progression by cell-cell and cell-matrix forces
Regulation of cell division and cell cycle progression by cell-cell and cell-matrix forces